封面
市場調查報告書
商品編碼
1812421

胸膜切片檢查市場按產品類型、程序、診斷用途、指導方法、最終用戶和地區分類

Pleural Biopsy Market, By Product Type, By Technique, By Diagnostic Application, By Guidance Method, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2025 年胸膜切片檢查市場價值估計為 3.304 億美元,預計到 2032 年將達到 5.034 億美元,2025 年至 2032 年的複合年成長率為 6.2%。

報告範圍 報告詳細資訊
基準年 2024 2025年的市場規模 3.304億美元
效能數據 2020-2024 預測期 2020-2024
預測期間(2025-2032年)的複合年成長率: 6.20% 2032年預測 5.034億美元

全球胸膜切片檢查市場是診斷醫療保健領域的一個重要領域,涵蓋從胸膜獲取組織樣本進行病理檢查的程序和技術。胸膜切片檢查是識別各種胸膜疾病的重要診斷工具,例如惡性肋膜間質細胞瘤、肺癌轉移、結核病以及其他發炎性和感染性胸膜疾病。該市場涵蓋多種操作方法,包括使用Abrams或Cope針進行的閉合性經皮切片檢查、胸腔鏡手術和CT引導下的經皮切片檢查,每種方法在診斷準確性和患者安全性方面均具有獨特的優勢。

呼吸系統疾病的盛行率不斷上升,加上環境中致癌性的暴露量不斷增加,以及人們對早期疾病檢測意識的不斷增強,這些因素極大地推動了市場的成長。全球醫療保健系統正在大力投資先進的診斷技術,隨著影像引導系統和微創技術的融合,胸膜切片檢查程序也變得越來越複雜。切片檢查儀器的技術進步、操作安全通訊協定的改進以及診斷準確性的提高,使得胸膜切片檢查成為全球現代肺胸醫學的重要組成部分。

市場動態

全球胸膜切片檢查市場正經歷強勁成長,這得益於多種相互關聯的因素。肺癌和間皮瘤發生率的上升是主要的成長催化劑,尤其是在全球老化社會中,環境和職業暴露於石棉及其他致癌性的情況日益突出。新興市場的技術創新,例如先進的影像引導切片檢查系統、微創胸腔鏡技術以及準確性和安全性更高的針吸活體組織切片設備的開發,是市場擴張的主要驅動力,因為它們能夠提高診斷準確性並減少併發症。

隨著醫療服務提供者日益重視早期疾病檢測和個人化醫療,市場成長也進一步受到推動。他們越來越意識到採集高品質組織樣本用於分子診斷和標靶治療選擇的重要性。全球胸膜切片檢查市場正經歷強勁成長,這主要歸因於多種相互關聯的因素,尤其是肺癌和間皮瘤發病率的上升,因為環境和職業暴露於石棉及其他致癌性持續影響全球老齡化人口,這成為主要的成長催化劑。

監管挑戰和新切片檢查設備的冗長核准流程也阻礙了市場成長。然而,新興經濟體醫療基礎設施的擴張、醫療支出的增加、醫療旅遊業的成長以及結合人工智慧和機器人輔助的下一代切片檢查技術的發展,正在帶來重大機遇,這些機會有望提高手術準確性、減少併發症,並擴大胸膜切片檢查程序的可用性和採用範圍,使全球更廣泛的患者群體受益。

本次調查的主要特點

  • 本報告對全球胸膜切片檢查市場進行了詳細分析,並以 2024 年為基準年,提供了預測期(2025-2032 年)的市場規模和年複合成長率(CAGR%)。
  • 它揭示了各個領域的潛在商機,並解釋了該市場有吸引力的投資提案矩陣。
  • 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。
  • 它根據公司亮點、產品系列、關鍵亮點、性能和策略等參數概述了全球胸膜切片檢查市場的主要企業。
  • 本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、最新策略、市場擴張和行銷策略做出明智的決策。
  • 全球胸膜切片檢查市場報告針對該行業的各個相關人員,包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
  • 相關人員可以透過用於分析全球胸膜切片檢查市場的各種策略矩陣更輕鬆地做出決策。

目錄

第 1 章:調查目標與先決條件

  • 調查目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告描述
    • 市場定義和範圍
  • 執行摘要

第3章:市場動態、法規與趨勢分析

  • 市場動態
  • 驅動程式
  • 抑制因素
  • 機會
  • 影響分析
  • 主要進展
  • 監管情景
  • 產品發布/核准
  • PEST分析
  • 波特分析
  • 併購場景
  • 產業趨勢

4. 2020-2032 年全球胸膜切片檢查市場(依產品類型)

  • 切片穿刺針和器械
  • 胸腔鏡及配件
  • 成像和引導系統
  • 輔助器具(吸引器、鑷子、套件等)

5. 2020-2032 年全球胸膜切片檢查市場(依技術分類)

  • 針吸切片(閉式針/艾布拉姆斯針)
  • 胸腔鏡胸膜切片檢查(內科胸腔鏡/VATS)
  • 開放性胸膜切片檢查

6. 2020-2032 年全球胸膜切片檢查市場(依診斷應用)

  • 惡性胸腔積水/惡性胸膜腫瘤(如間皮瘤、轉移性癌症)
  • 感染性胸膜疾病(例如結核病、細菌性/真菌性胸膜炎)
  • 發炎和自體免疫疾病(例如類風濕性胸膜炎、紅斑性狼瘡)
  • 其他特發性或原因不明的胸腔積液

7. 2020-2032 年全球胸膜切片檢查市場(依指導方法)

  • 影像引導(CT引導、超音波引導)
  • 無感

8. 2020-2032 年全球胸膜切片檢查市場(依最終使用者分類)

  • 醫院
  • 專科診所
  • 診斷中心
  • 門診手術中心
  • 學術和研究機構

9. 2020-2032 年全球胸膜切片檢查市場(按地區)

  • 北美洲
      • 美國
      • 加拿大
  • 拉丁美洲
      • 巴西
      • 阿根廷
      • 墨西哥
      • 其他拉丁美洲
  • 歐洲
      • 德國
      • 英國
      • 西班牙
      • 法國
      • 義大利
      • 俄羅斯
      • 其他歐洲國家
  • 亞太地區
      • 中國
      • 印度
      • 日本
      • 澳洲
      • 韓國
      • ASEAN
      • 其他亞太地區
  • 中東
      • 海灣合作理事會國家
      • 以色列
      • 其他中東地區
  • 非洲
      • 南非
      • 北非
      • 中部非洲

第10章 競爭格局

  • Olympus Corporation
  • Boston Scientific Corporation
  • Cook Medical
  • CONMED Corporation
  • Medtronic plc
  • Braun Melsungen AG
  • Hologic Inc.
  • BD(Becton, Dickinson and Company)
  • FUJIFILM Holdings Corporation
  • KARL STORZ SE & Co. KG
  • Ethicon(Johnson & Johnson)
  • Argon Medical Devices
  • Richard Wolf GmbH
  • Smiths Medical

第 11 章分析師建議

  • 機會
  • 分析師觀點
  • Coherent Opportunity Map

第12章參考文獻與調查方法

  • 參考
  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI8455

Pleural Biopsy Market is estimated to be valued at USD 330.4 Mn in 2025 and is expected to reach USD 503.4 Mn by 2032, growing at a compound annual growth rate (CAGR) of 6.2% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 330.4 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 6.20% 2032 Value Projection: USD 503.4 Mn

The global pleural biopsy market represents a critical segment within the diagnostic healthcare landscape, encompassing procedures and technologies designed to extract tissue samples from the pleura for pathological examination. Pleural biopsy procedures serve as essential diagnostic tools for identifying various pleural conditions, including malignant pleural mesothelioma, lung cancer metastases, tuberculosis, and other inflammatory or infectious pleural diseases. The market encompasses multiple procedural approaches, including closed pleural biopsy using Abrams or Cope needles, thoracoscopic procedures, and CT-guided percutaneous biopsies, each offering distinct advantages in terms of diagnostic accuracy and patient safety.

The increasing prevalence of respiratory diseases, coupled with rising environmental exposure to carcinogenic substances and growing awareness of early disease detection, has significantly propelled market growth. Healthcare systems worldwide are witnessing substantial investments in advanced diagnostic technologies, with pleural biopsy procedures becoming increasingly sophisticated through integration of imaging guidance systems and minimally invasive techniques. The market's evolution is further driven by technological advancements in biopsy instruments, improved procedural safety protocols, and enhanced diagnostic accuracy, making pleural biopsy an indispensable component of modern pulmonary and thoracic medicine practices globally.

Market Dynamics

The global pleural biopsy market is experiencing robust growth, driven by multiple interconnected factors. The increasing incidence of lung cancer and mesothelioma serves as a primary growth catalyst, particularly as environmental and occupational exposures to asbestos and other carcinogenic substances continue to manifest in aging populations worldwide. Advanced technological innovations, including the development of sophisticated imaging-guided biopsy systems, minimally invasive thoracoscopic techniques, and enhanced needle biopsy instruments with improved precision and safety profiles, significantly drive market expansion by enabling more accurate diagnoses with reduced procedural complications.

The growing emphasis on early disease detection and personalized medicine approaches further accelerates market growth, as healthcare providers increasingly recognize the critical importance of obtaining high-quality tissue samples for molecular diagnostics and targeted therapy selection. The global pleural biopsy market is experiencing robust growth, driven by multiple interconnected factors. A key growth catalyst is the rising incidence of lung cancer and mesothelioma, especially as environmental and occupational exposures to asbestos and other carcinogenic substances continue to affect aging populations worldwide.

Regulatory challenges and lengthy approval processes for new biopsy devices also impede market growth. Nevertheless, significant opportunities emerge through expanding healthcare infrastructure in emerging economies, increasing healthcare expenditure, growing medical tourism, and the development of next-generation biopsy technologies incorporating artificial intelligence and robotic assistance, which promise to enhance procedural accuracy, reduce complications, and expand the accessibility of pleural biopsy procedures to broader patient populations globally.

Key Features of the Study

  • This report provides in-depth analysis of the global pleural biopsy market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global pleural biopsy market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Olympus Corporation, Boston Scientific Corporation, Cook Medical, CONMED Corporation, Medtronic plc, B. Braun Melsungen AG, Hologic Inc., BD (Becton, Dickinson and Company), FUJIFILM Holdings Corporation, KARL STORZ SE & Co. KG, Ethicon (Johnson & Johnson), Argon Medical Devices, Richard Wolf GmbH, and Smiths Medical
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global pleural biopsy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pleural biopsy market

Market Segmentation

  • Product Type Insights (Revenue, USD Mn, 2020 - 2032)
    • Biopsy Needles and Instruments
    • Thoracoscopes and Accessories
    • Imaging and Guidance Systems
    • Ancillary Equipment (suction devices, forceps, kits, etc.)
  • Technique Insights (Revenue, USD Mn, 2020 - 2032)
    • Needle Biopsy (Closed Needle/Abrams Needle)
    • Thoracoscopic Pleural Biopsy (Medical Thoracoscopy/VATS)
    • Open Surgical Pleural Biopsy
  • Diagnostic Application Insights (Revenue, USD Mn, 2020 - 2032)
    • Malignant Pleural Effusion and Pleural Malignancies (e.g., mesothelioma, metastatic cancers)
    • Infectious Pleural Diseases (e.g., tuberculosis, bacterial/fungal pleuritis)
    • Inflammatory and Autoimmune Conditions (e.g., rheumatoid pleuritis, lupus)
    • Other Idiopathic or Unexplained Pleural Effusions
  • Guidance Method Insights (Revenue, USD Mn, 2020 - 2032)
    • Image-Guided (CT-guided, Ultrasound-guided)
    • Non-Guided
  • End User Insights (Revenue, USD Mn, 2020 - 2032)
    • Hospitals
    • Specialty Clinics
    • Diagnostic Centers
    • Ambulatory Surgical Centers
    • Academic and Research Institutes
  • Regional Insights (Revenue, USD Mn, 2020 - 2032)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Olympus Corporation
    • Boston Scientific Corporation
    • Cook Medical
    • CONMED Corporation
    • Medtronic plc
    • Braun Melsungen AG
    • Hologic Inc.
    • BD (Becton, Dickinson and Company)
    • FUJIFILM Holdings Corporation
    • KARL STORZ SE & Co. KG
    • Ethicon (Johnson & Johnson)
    • Argon Medical Devices
    • Richard Wolf GmbH
    • Smiths Medical

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Pleural Biopsy Market, By Product Type
    • Global Pleural Biopsy Market, By Technique
    • Global Pleural Biopsy Market, By Diagnostic Application
    • Global Pleural Biopsy Market, By Guidance Method
    • Global Pleural Biopsy Market, By End User
    • Global Pleural Biopsy Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Driver
  • Restraint
  • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Industry Trends

4. Global Pleural Biopsy Market, By Product Type, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Biopsy Needles and Instruments
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Thoracoscopes and Accessories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Imaging and Guidance Systems
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Ancillary Equipment (suction devices, forceps, kits, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

5. Global Pleural Biopsy Market, By Technique, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Needle Biopsy (Closed Needle/Abrams Needle)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Thoracoscopic Pleural Biopsy (Medical Thoracoscopy/VATS)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Open Surgical Pleural Biopsy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

6. Global Pleural Biopsy Market, By Diagnostic Application, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Malignant Pleural Effusion and Pleural Malignancies (e.g., mesothelioma, metastatic cancers)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Infectious Pleural Diseases (e.g., tuberculosis, bacterial/fungal pleuritis)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Inflammatory and Autoimmune Conditions (e.g., rheumatoid pleuritis, lupus)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Other Idiopathic or Unexplained Pleural Effusions
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

7. Global Pleural Biopsy Market, By Guidance Method, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Image-Guided (CT-guided, Ultrasound-guided)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Non-Guided
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

8. Global Pleural Biopsy Market, By End User, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Specialty Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Diagnostic Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Academic and Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

9. Global Pleural Biopsy Market, By Region, 2020 - 2032, Value (USD Mn)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Mn)
    • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Mn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Technique, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Diagnostic Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Guidance Method, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Technique, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Diagnostic Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Guidance Method, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Technique, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Diagnostic Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Guidance Method, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Technique, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Diagnostic Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Guidance Method, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Technique, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Diagnostic Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Guidance Method, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Technique, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Diagnostic Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Guidance Method, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Mn)
      • South Africa
      • North Africa
      • Central Africa

10. Competitive landscape

  • Olympus Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Boston Scientific Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Cook Medical
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • CONMED Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Medtronic plc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Braun Melsungen AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Hologic Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • BD (Becton, Dickinson and Company)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • FUJIFILM Holdings Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • KARL STORZ SE & Co. KG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Ethicon (Johnson & Johnson)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Argon Medical Devices
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Richard Wolf GmbH
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Smiths Medical
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

11. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

12. References and Research Methodology

  • References
  • Research Methodology
  • About us